Zhejiang haizheng pharmaceutical co., ltd.

Zhejiang Haizheng Pharmaceutical Co., Ltd. SH: 600267 was established in 1956, located in Taizhou, Zhejiang Province, a port city in the southeast of China. Haizheng has become a leading API manufacturer in China. Haizheng * * * has about 5,000 employees, of which more than one third are scientific and technical personnel. In 2000, Shanghai was listed on the Shanghai Stock Exchange. As one of the largest production bases of antibiotics and anti-tumor drugs in China, Haizheng is committed to providing better services to customers around the world by using its own R&D resources.

Zhejiang Haizheng Pharmaceutical Co., Ltd. was approved by Zhejiang Provincial People's Government, and Zhejiang Fazheng [1998]No. 12 "Reply on the Establishment of Zhejiang Haizheng Pharmaceutical Co., Ltd.". A joint stock limited company established by 8 shareholders including Zhejiang Haizheng Group Co., Ltd., SDIC Pharmaceutical Investment Co., Ltd., Sanlong Investment (China) Co., Ltd., Sichuan Antimicrobial Industry Research Institute of China Pharmaceutical Group Corporation (formerly Sichuan Antimicrobial Industry Research Institute of State Administration of Medicine), Shanghai Pharmaceutical Industry Research Institute, China Pharmaceutical University, Zhejiang Intel Pharmaceutical Co., Ltd. and Shanghai Fosun Zhao Hui Pharmaceutical Co., Ltd. on the basis of the former Zhejiang Haimen Pharmaceutical Factory. The company's shares were listed on the Shanghai Stock Exchange on July 25th, 2000.